Concepedia
Statistics
Publications
12
Citations
740
H-Index
11
Active since
2003
Affiliations
Jikei University School of Medicine(Current)
Dana-Farber Cancer Institute
Taiho Pharmaceutical (Japan)
Chiba University
VA Boston Healthcare System
Jiro Minami is an author at Jikei University School of Medicine specializing in medicine, oncology, and multiple myeloma.
Publications per year
2003–2018
Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma
Naoya Mimura, Mariateresa Fulciniti, Güllü Görgün et al. · Blood · 2012 · 435 citations · Full text
Life Sciences, Molecular Biology, Molecular Medicine +9
Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma
Claire Fabre, Naoya Mimura, Kathryn Bobb et al. · Clinical Cancer Research · 2012 · 83 citations · Full text
Medicine, Oncology, Pharmacology +10
Selective and Potent Akt Inhibition Triggers Anti-Myeloma Activities and Enhances Fatal Endoplasmic Reticulum Stress Induced by Proteasome Inhibition
Naoya Mimura, Teru Hideshima, Toshiyasu Shimomura et al. · Cancer Research · 2014 · 78 citations · Full text
Medicine, Oncology, Pharmacology +15
Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma
Hideki Nakasone, Yoshinobu Kanda, Tomoki Ueda et al. · American Journal of Hematology · 2009 · 24 citations
Medicine, Hematology, Oncology +17
Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells
Rikio Suzuki, Shohei Kikuchi, Takeshi Harada et al. · PLoS ONE · 2015 · 22 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 12